ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for discussion Register to chat with like-minded investors on our interactive forums.

BVXP Bioventix Plc

4,425.00
-50.00 (-1.12%)
Last Updated: 14:55:20
Delayed by 15 minutes
Share Name Share Symbol Market Type Share ISIN Share Description
Bioventix Plc LSE:BVXP London Ordinary Share GB00B4QVDF07 ORD 5P
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  -50.00 -1.12% 4,425.00 4,400.00 4,450.00 4,475.00 4,425.00 4,475.00 1,791 14:55:20
Industry Sector Turnover Profit EPS - Basic PE Ratio Market Cap
Coml Physical, Biologcl Resh 12.82M 8.37M 1.6071 27.53 230.51M
Bioventix Plc is listed in the Coml Physical, Biologcl Resh sector of the London Stock Exchange with ticker BVXP. The last closing price for Bioventix was 4,475p. Over the last year, Bioventix shares have traded in a share price range of 3,450.00p to 5,060.00p.

Bioventix currently has 5,209,333 shares in issue. The market capitalisation of Bioventix is £230.51 million. Bioventix has a price to earnings ratio (PE ratio) of 27.53.

Bioventix Share Discussion Threads

Showing 1376 to 1399 of 1575 messages
Chat Pages: 63  62  61  60  59  58  57  56  55  54  53  52  Older
DateSubjectAuthorDiscuss
24/11/2021
13:46
Yeah there is no quick win here. It went from undervalued to overvalued and will now settle down hopefully somewhere around thirty quid. Reinvest the dividends if you want some growth, and hope that at least one of the current research projects pays off.
stepone68
24/11/2021
10:06
Thanks for the replies chaps - sit and wait then.
On Avon I was lucky to get out at £30 and no way will I be getting back in.
Suet

suetballs
24/11/2021
09:22
Never a short term trade. One to buy and put away like a young claret.
igbertsponk
24/11/2021
09:20
Short term no because this company does not communicate a lot - if previous years are a guide the next trading statement will be Interim results at the end of March. Between now and then it will just be the mood of the market that moves the share price
sharw
24/11/2021
09:06
Can anyone see any short term upside here?
Got in late and currently sitting on a 20% loss.
Suet

suetballs
21/11/2021
17:58
Worth following him on all companies he writes up. Remarkably thorough and careful with his opinions
apad

apad
21/11/2021
17:23
Fair play - that is a really good write up on a company.
trident5
21/11/2021
16:15
BIOVENTIX: FY 2021 Results Unveil Record H2 Profit (+14%) While Finite Troponin Income Shifts Longer-Term Perspective Towards Pyrene Project And Alzheimer’s Research #BVXP


"Valuing the pipeline at a negative £5m seems about right if annual R&D costs are £1.2m and research commercialisation is not expected until 2025 at the earliest"

tmfmayn
18/11/2021
17:56
Good spot. The FY 2020 Employees total costs in note 6 seems to have been accidentally copied and pasted into note 7!

Coincidentally I have just watched a newly posted video with Terry Smith, where he asks the question, "does anyone read the accounts anymore?"(from point 12:30 in the video):

robinnicolson
16/11/2021
19:43
Note 7 (Directors Rem) just doesn't add up. By about £600k. Error, nothing suspicious. Obviously they don't read here or they'd have corrected by now. I've sent them a message.
igbertsponk
16/11/2021
18:12
Less interested market means less buyers and sellers and less liquidity. Could also be the usual market maker shenanigans.
doctor888
16/11/2021
17:26
Igbert - I've not looked at the note, but is the comparative issue related to the additional 700k revenue from a couple of years ago which was backdated?

Jim - don't know, sorry.

stepone68
16/11/2021
15:57
Why is the spread increasing?
jimboyce
11/11/2021
16:15
Though Note 7 of the accounts needs a bit of work! Comparative total is somewhat out. OOPS!
igbertsponk
11/11/2021
16:11
They don't waste oodles on such presentation nonsense. They bill customers, spend a very little on costs and distribute the vast majority of sales revenue as dividends. And have done for eons now. Best run company on the exchange.
igbertsponk
11/11/2021
16:02
Full list of bvxp rns's here,
jonut
11/11/2021
15:44
I hoped to find the latest BVXP presentation to investors, but I can't find anything later that 2019. I expected to find it on the BVXP web site, but that gives surprisingly little information.

Can anyone tell me where I can find what I seek?

gnnmartin
23/10/2021
12:33
SP seems to be finding a floor mainly around yield. Finncap with a 4300 target....that would be nice.?
nigeldoug1
21/10/2021
18:02
FWIW ...



- last 6 months recovery confirmed

IMHO.

piedro
20/10/2021
11:57
I do think a buyout will happen here eventually. And if it happens anywhere over £30 I'll be happy enough, with my initial buy at £6 and a top up at 17. It would obviously be a bit disappointing, but hopefully we have time to collect a few dividends between now and then :-)
stepone68
20/10/2021
11:41
stepone68: Thanks for the clarification/confirmation. The question you are asking is puzzling; I'd be interested if anyone has thoughts on this (especially the company, obviously). Perhaps there already are provisions in the existing contract for after 2032 (in case any production is requested), or perhaps not?
vprt
20/10/2021
11:24
This will drop all the way to £30, at which time someone (Chinese) will make an offer for the company.
a1samu
20/10/2021
10:05
Mistimed my buy here - loss now 12% and can't see much short term upside.
May bail and put more into Shell.
Suet

suetballs
20/10/2021
08:02
For the 9 month comparison of FY2021 to FY2020, Roche core lab diagnostics increased 26% so plenty of demand and more to come as we get on top of COVID.
doctor888
Chat Pages: 63  62  61  60  59  58  57  56  55  54  53  52  Older

Your Recent History

Delayed Upgrade Clock